Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates

Detalhes bibliográficos
Autor(a) principal: Piemontese, Luca
Data de Publicação: 2018
Outros Autores: Tomás, Daniel, Hiremathad, Asha, Capriati, Vito, Candeias, Emanuel, Cardoso, Sandra M., Chaves, Sílvia, Santos, M. Amélia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/107711
https://doi.org/10.1080/14756366.2018.1491564
Resumo: A new series of multifunctional hybrids, based on the structure of the donepezil (DNP) drug, have been developed and evaluated as potential anti Alzheimer's disease (AD) agents. The rationale of this study was the conjugation of a benzylpiperidine/benzylpiperazine moiety with derivatives of bioactive heterocyclics (benzimidazole or benzofuran), to mimic the main structure of DNP and to endow the hybrids with additional relevant properties such as inhibition of amyloid beta (Aβ) peptide aggregation, antioxidant activity and metal chelation. Overall, they showed good activity for AChE inhibition (IC50=4.0-30.0 μΜ) and moderate ability for inhibition of Aβ1-42 self-mediated aggregation. The hybrids containing chelating groups showed improvement in the inhibition of Cu-induced Aβ42 aggregation and the antioxidant capacity. Moreover, neuroprotective effects of these compounds were evidenced in neuroblastoma cells after Aβ1-42 induced toxicity. Structure-activity relationship allowed the identification of some promising compounds and the main determinant structural features for the targeted properties.
id RCAP_6b3cede4eca126efc15daf5674824f24
oai_identifier_str oai:estudogeral.uc.pt:10316/107711
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidatesAlzheimer’s diseasemultipotent drugsdonepezil mimeticsAChE inhibitorsanti-Aβ aggregationAcetylcholinesteraseAlzheimer DiseaseAmyloid beta-PeptidesAntioxidantsCaco-2 CellsCell Line, TumorCell SurvivalCholinesterase InhibitorsDonepezilDose-Response Relationship, DrugHumansIndansModels, MolecularMolecular StructurePiperidinesProtein AggregatesStructure-Activity RelationshipA new series of multifunctional hybrids, based on the structure of the donepezil (DNP) drug, have been developed and evaluated as potential anti Alzheimer's disease (AD) agents. The rationale of this study was the conjugation of a benzylpiperidine/benzylpiperazine moiety with derivatives of bioactive heterocyclics (benzimidazole or benzofuran), to mimic the main structure of DNP and to endow the hybrids with additional relevant properties such as inhibition of amyloid beta (Aβ) peptide aggregation, antioxidant activity and metal chelation. Overall, they showed good activity for AChE inhibition (IC50=4.0-30.0 μΜ) and moderate ability for inhibition of Aβ1-42 self-mediated aggregation. The hybrids containing chelating groups showed improvement in the inhibition of Cu-induced Aβ42 aggregation and the antioxidant capacity. Moreover, neuroprotective effects of these compounds were evidenced in neuroblastoma cells after Aβ1-42 induced toxicity. Structure-activity relationship allowed the identification of some promising compounds and the main determinant structural features for the targeted properties.Taylor & Francis2018-12info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/107711http://hdl.handle.net/10316/107711https://doi.org/10.1080/14756366.2018.1491564eng1475-63661475-6374Piemontese, LucaTomás, DanielHiremathad, AshaCapriati, VitoCandeias, EmanuelCardoso, Sandra M.Chaves, SílviaSantos, M. Améliainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-28T09:14:04Zoai:estudogeral.uc.pt:10316/107711Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:24:01.905853Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates
title Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates
spellingShingle Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates
Piemontese, Luca
Alzheimer’s disease
multipotent drugs
donepezil mimetics
AChE inhibitors
anti-Aβ aggregation
Acetylcholinesterase
Alzheimer Disease
Amyloid beta-Peptides
Antioxidants
Caco-2 Cells
Cell Line, Tumor
Cell Survival
Cholinesterase Inhibitors
Donepezil
Dose-Response Relationship, Drug
Humans
Indans
Models, Molecular
Molecular Structure
Piperidines
Protein Aggregates
Structure-Activity Relationship
title_short Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates
title_full Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates
title_fullStr Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates
title_full_unstemmed Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates
title_sort Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates
author Piemontese, Luca
author_facet Piemontese, Luca
Tomás, Daniel
Hiremathad, Asha
Capriati, Vito
Candeias, Emanuel
Cardoso, Sandra M.
Chaves, Sílvia
Santos, M. Amélia
author_role author
author2 Tomás, Daniel
Hiremathad, Asha
Capriati, Vito
Candeias, Emanuel
Cardoso, Sandra M.
Chaves, Sílvia
Santos, M. Amélia
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Piemontese, Luca
Tomás, Daniel
Hiremathad, Asha
Capriati, Vito
Candeias, Emanuel
Cardoso, Sandra M.
Chaves, Sílvia
Santos, M. Amélia
dc.subject.por.fl_str_mv Alzheimer’s disease
multipotent drugs
donepezil mimetics
AChE inhibitors
anti-Aβ aggregation
Acetylcholinesterase
Alzheimer Disease
Amyloid beta-Peptides
Antioxidants
Caco-2 Cells
Cell Line, Tumor
Cell Survival
Cholinesterase Inhibitors
Donepezil
Dose-Response Relationship, Drug
Humans
Indans
Models, Molecular
Molecular Structure
Piperidines
Protein Aggregates
Structure-Activity Relationship
topic Alzheimer’s disease
multipotent drugs
donepezil mimetics
AChE inhibitors
anti-Aβ aggregation
Acetylcholinesterase
Alzheimer Disease
Amyloid beta-Peptides
Antioxidants
Caco-2 Cells
Cell Line, Tumor
Cell Survival
Cholinesterase Inhibitors
Donepezil
Dose-Response Relationship, Drug
Humans
Indans
Models, Molecular
Molecular Structure
Piperidines
Protein Aggregates
Structure-Activity Relationship
description A new series of multifunctional hybrids, based on the structure of the donepezil (DNP) drug, have been developed and evaluated as potential anti Alzheimer's disease (AD) agents. The rationale of this study was the conjugation of a benzylpiperidine/benzylpiperazine moiety with derivatives of bioactive heterocyclics (benzimidazole or benzofuran), to mimic the main structure of DNP and to endow the hybrids with additional relevant properties such as inhibition of amyloid beta (Aβ) peptide aggregation, antioxidant activity and metal chelation. Overall, they showed good activity for AChE inhibition (IC50=4.0-30.0 μΜ) and moderate ability for inhibition of Aβ1-42 self-mediated aggregation. The hybrids containing chelating groups showed improvement in the inhibition of Cu-induced Aβ42 aggregation and the antioxidant capacity. Moreover, neuroprotective effects of these compounds were evidenced in neuroblastoma cells after Aβ1-42 induced toxicity. Structure-activity relationship allowed the identification of some promising compounds and the main determinant structural features for the targeted properties.
publishDate 2018
dc.date.none.fl_str_mv 2018-12
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/107711
http://hdl.handle.net/10316/107711
https://doi.org/10.1080/14756366.2018.1491564
url http://hdl.handle.net/10316/107711
https://doi.org/10.1080/14756366.2018.1491564
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1475-6366
1475-6374
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Taylor & Francis
publisher.none.fl_str_mv Taylor & Francis
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134125926383616